Free Trial
ASX:OPT

Opthea (OPT) Stock Price, News & Analysis

Opthea logo

About Opthea Stock (ASX:OPT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
504,572 shs
Average Volume
N/A
Market Capitalization
A$790.69 million
P/E Ratio
N/A
Dividend Yield
0.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opthea and its competitors with MarketBeat's FREE daily newsletter.

OPT Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

OPT Stock Analysis - Frequently Asked Questions

Opthea Limited (ASX:OPT) released its earnings results on Friday, August, 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.00. Opthea had a negative net margin of 182,616.58% and a positive trailing twelve-month return on equity of 543.34%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Opthea investors own include Skyworks Solutions (SWKS), Teladoc Health (TDOC), Vaxart (VXRT), Zion Oil & Gas (ZN), AST SpaceMobile (ASTS), Appian (APPN) and American Well (AMWL).

Company Calendar

Last Earnings
8/09/2019
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:OPT
CIK
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$220.24 million
Net Margins
-182,616.58%
Pretax Margin
N/A
Return on Equity
543.34%
Return on Assets
-83.43%

Debt

Debt-to-Equity Ratio
-186.85
Current Ratio
2.94
Quick Ratio
4.25

Sales & Book Value

Annual Sales
A$199.01 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
10.29
Book Value
A($0.11) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,230,000,000
Free Float
N/A
Market Cap
A$790.69 million
Optionable
Not Optionable
Beta
1.61
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (ASX:OPT) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners